Event Details
December 01, 2025
Description
ODYSSEY clinical trial program.
Participants (4)
| Name | Type | Mentions | |
|---|---|---|---|
| Regeneron | organization | 22 | View Entity |
| patients | person | 2 | View Entity |
| Sanofi | organization | 26 | View Entity |
| Investigators | person | 26 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_025890.jpg
This document appears to be a printout of a news article or press release compilation regarding the FDA approval and market analysis of the Regeneron/Sanofi cholesterol drug, Praluent. It details financial projections, physician surveys, and quotes from executives at Regeneron, Sanofi, and CVS Caremark regarding pricing and accessibility. While the document bears a House Oversight stamp and mentions Donald Trump in a disconnected headline, the content focuses entirely on the pharmaceutical industry.
Related Events
Events with shared participants
ODYSSEY Phase 3 program: A comprehensive clinical trial program for an investigational LDL cholesterol lowering therapy (Praluent), involving 14 global trials and over 23,500 patients.
Date unknown • Global
ODYSSEY Phase 3 program: A comprehensive clinical trial program for PRALUENT, including 14 global trials with over 23,500 patients.
Date unknown • Global
ODYSSEY Phase 3 program: A large-scale clinical trial program for the investigational LDL cholesterol-lowering therapy, Praluent (alirocumab), involving over 23,500 patients in 14 global trials.
Date unknown • Global
Investor Relations Conference Call hosted by Sanofi and Regeneron to discuss Praluent.
2015-07-24 • Teleconference / Webcast
Investor Relations Conference Call on Praluent for the financial community.
2015-07-24 • Teleconference / Webcast
The ODYSSEY clinical trial program was conducted for the drug Praluent.
Date unknown • worldwide
Trading of Regeneron shares was halted pending news.
Date unknown
The FDA clearing the drug Praluent for patients with heterozygous familial hypercholesterolemia and certain types of heart disease.
Date unknown
Cohen is under investigation for bank fraud and violating campaign-finance law.
Date unknown • U.S.
Discovery of hidden cameras
Date unknown • Epstein's New York Residence
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event